Christopher Pasquale Profile - Barclays Analyst
137 Followers
Christopher Pasquale's Stock Coverage
| BLCOBausch + Lomb Corporation | Nov 17, 2026 | BUY | Reiterated | $27.00 | 2Ratings | +9.35% | ||
| MMEDMiniMed Group, Inc. | Nov 13, 2026 | HOLD | Reiterated | $20.00 | 2Ratings | ― | ― | |
| AVRAnteris Technologies Global Corp. | Nov 13, 2026 | HOLD | Reiterated | $9.00 | 3Ratings | ― | ― | |
| HUMAHumacyte | Nov 11, 2026 | HOLD | Reiterated | $0.60 | 3Ratings | -54.70% | ||
| ALCAlcon | Nov 11, 2026 | HOLD | Reiterated | CHF67.49 | 4Ratings | +6.00% | ||
| BDXBecton Dickinson | Nov 10, 2026 | SELL | Reiterated | $195.00 | 5Ratings | -3.33% | ||
| ZBHZimmer Biomet Holdings | Nov 09, 2026 | HOLD | Reiterated | $115.00 | 14Ratings | -5.98% | ||
| TMDXTransMedics Group | Nov 09, 2026 | BUY | Reiterated | $120.00 | 2Ratings | +8.65% | ||
| SENSSenseonics Holdings | Nov 09, 2026 | HOLD | Reiterated | $11.00 | 6Ratings | -9.03% | ||
| LIVNLivaNova | Nov 09, 2026 | BUY | Reiterated | $120.00 | 3Ratings | +11.10% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Christopher Pasquale activity FAQ
What is the performance of Christopher Pasquale's recommendations?
The percentage of profitable recommendations made by Christopher Pasquale is 62.76%, and the average return per transaction is 10.60%.
What stocks does Christopher Pasquale cover?
Christopher Pasquale mostly covers Bausch + Lomb Corporation, Anteris Technologies Global Corp., MiniMed Group, Inc. stocks.
What was Christopher Pasquale's most profitable rating?
Christopher Pasquale’s most profitable rating was a buy on ABMD stock on May 04, 2017. The return on the trade was 167.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here
